Randomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasis

PLoS Neglected Tropical Diseases

Volumn 5, Issue 7, 2011, Pages

  Bisoffi, Zeno ^a   Buonfrate, Dora ^a   Angheben, Andrea ^a   Boscolo, Marina ^a   Anselmi, Mariella ^a   Marocco, Stefania ^a   Monteiro, Geraldo ^a   Gobbo, Maria ^a   Bisoffi, Giulia ^b   Gobbi, Federico ^a  

^a Ospedale S Cuore   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN; TIABENDAZOLE; ANTINEMATODAL AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DIZZINESS; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; PHASE 3 CLINICAL TRIAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SOMNOLENCE; STRONGYLOIDIASIS; TREATMENT OUTCOME; ANIMAL; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FECES; MIDDLE AGED; NONPARAMETRIC TEST; PARASITOLOGY; STRONGYLOIDES STERCORALIS;

ADULT; ANIMALS; ANTINEMATODAL AGENTS; CHI-SQUARE DISTRIBUTION; FECES; FEMALE; HUMANS; IVERMECTIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; THIABENDAZOLE; TREATMENT OUTCOME;

EID: 79960953770     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001254     Document Type: Article

References (33)

1. Pirisi M, Salvador E, Bisoffi Z, Gobbo M, Smirne C, et al. (2006) Unsuspected strongyloidiasis in hospitalized elderly patients with and without eosinophilia. Clin Micr and Infect 12: 787-792.
2. Abrescia F, Falda A, Caramaschi G, Scalzini A, Gobbi F, et al. (2009) Reemergence of strongyloidiasis, Northern Italy. Emerg Infect Dis 15 (9): 1531-1533.
3. Olsen A, Van Lieshout L, Marti H, Polderman T, Polman K, et al. (2009) Strongyloidiasis - the most neglected of the neglected tropical diseases? Trans R Soc Trop Med Hyg 103: 967-972.
4. Concha R, Harrington W, Rogers AI, (2005) Intestinal Strongyloidiasis. Recognition, management, and determinants of outcome. J Clin Gastroenterol 39: 203-211.
5. Gilles HM, (2003) Soil-transmitted helminthes (Geohelminths). In: Cook GC, Zula AI, editors. Manson's Tropical Diseases, 21st edition pp. 1545-1549.
6. Segarra-Newnham M, (2007) Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection. Ann Pharmacother 41 (12): 1992-2001.
7. Keiser PB, Nutman TB, (2004) Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 17: 208-217.
8. Roxby AC, Gottlieb GS, Limaye AP, (2009) Strongyloidiasis in transplant patients. Clin Infect Dis 49: 1411-1423.
9. Fowler CG, Lindsay I, Levin J, Sweny P, Fernando ON, et al. (1982) Recurrent hyperinfestation with Strongyloides stercoralis in a renal allograft recipient. Br Med J 285: 1394.
10. Venizelos PC, Lopata M, Bardawil WA, Sharp JT, (1980) Respiratory failure due to Strongyloides stercoralis in a patient with a renal transplant. Chest 78: 104-106.
11. Gilbert DN, Moellering RC, Eliopoulos GM, Chambers HF, Saag MS, (2010) The Sanford Guide to antimicrobial therapy 2010 Fortieth Edition.
12. WHO model formulary 2008 Stuart MC, Kouimtzi M, Hill SR, eds. Available http://www.who.int/selection_medicines/list/WMF2008.pdf via the Internet. Accessed 4 April 2011.
13. Suputtamongkol Y, Premasathian N, Bhumimuang K, Waywa D, Nilganuwong S, et al. (2011) Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis. PLoS Negl Trop Dis 5 (5): e1044.
14. Nontasut P, Muennoo C, Sa-nguankiat S, Fongsri S, Vichit A, (2005) Prevalence of strongyloidiasis in Northern Thailand and treatment with ivermectin vs albendazole. Southeast Asian J Trop Med Public Health 36 (2): 442-444.
15. Datry A, Hilmarsdottir I, Mayorga-Sagastume R, Lyagoubi M, Gaxotte P, et al. (1994) Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases. Trans R Soc Trop Med Hyg 88: 344-345.
16. Marti H, Haji HJ, Savioli L, Chwaya HM, Mgeni AF, et al. (1996) A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am J Trop Med Hyg 55: 477-481.
17. Adenusi AA, Oke AO, Adenusi AO, (2003) Comparison of ivermectin and thiabendazole in the treatment of uncomplicated human Strongyloides stercoralis infection. African Journal of Biotechnology 2 (11): 465-469.
18. Gann PH, Neva FA, Gam AA, (1994) A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis 169: 1076-1079.
19. Naquira C, Jimenez G, Guerra JG, Bernal R, Nalin DR, et al. (1989) Ivermectin for human strongyloidiasis and other intestinal helminthes. Am J Trop Med Hyg 40 (3): 304-309.
20. Shikiya K, Kinjo N, Uehara T, Uechi H, Ohshiro J, et al. (1992) Efficacy of ivermectin against Strongyloides stercoralis in humans. Internal Medicine 31: 310-312.
21. Steinmann P, Zhou X-N, Du Z-W, Jiang J-Y, Xiao S-H, et al. (2008) Tribendimidine and albendazole for treating soil-transmitted helminthes, Strongyloides stercoralis and Taenia spp: open-label randomized trial. PLoS Negl Trop Dis 2 (10): e322.
22. Toma H, Sato Y, Shiroma Y, Kobayashi J, Shimabukuro I, et al. (2000) Comparative studies on the efficacy of three anthelminthics on the treatment of human strongyloidiasis in Okinawa, Japan. Southeast Asian J Trop Med Public Health 31: 147-151.
23. Siddiqui AA, Berk SL, (2001) Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 33: 1040-1047.
24. Uparanukraw P, Phongsri S, Morakote N, (1999) Fluctuations of larval excretion in Strongyloides stercoralis infection. Am J Trop Med Hyg 60 (6): 967-973.
25. Biggs BA, Caruana S, Mihrshahi S, Jolley D, Leydon J, et al. (2009) Short report: management of chronic strongyloidiasis in immigrants snd refugees: is serologic testing useful? Am J Trop Med Hyg 80 (5): 788-791.
26. Kobayashi J, Sato Y, Toma H, Takara M, Shiroma Y, (1994) Application of enzyme immunoassay for postchemotherapy evaluation of human strongyloidiasis. Diagn Microbiol Infect Dis 18 (1): 19-23.
27. Machado ER, Ueta MT, Gonçalves-Pires MRF, Alves de Olivera JB, Faccioli LH, et al. (2001) Diagnosis of human strongyloidiasis using particulate antigen of two strain of Strongyloides venezuelensis in indirect immunofluorescence antibody test. Experimental parassitology 99: 52-55.
28. Page WA, Dempsey K, McCarthy SJ, (2006) Utility of serological follow up of chronic strongyloidiasis after anthelminthic chemotherapy. Trans R Soc Trop Med Hyg 100 (11): 1056-62.
29. Boscolo M, Gobbo M, Mantovani W, Degani M, Anselmi M, et al. (2007) Evaluation of an Indirect Immunofluorescence Assay for Strongyloidiasis as a Tool for Diagnosis and Follow-up. Clin Vac Immunol 14 (2): 129-133.
30. Loutfy MR, Wilson M, Keystone JS, Kain KC, (2002) Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg 66 (6): 749-752.
31. Montori VM, Guyatt GH, (2001) Intention-to-treat principle. CMAJ 165 (10): 1339-41.
32. Verweji JJ, Canales M, Polman K, Ziem J, Brienen EAT, et al. (2009) Molecular diagnosis of Strongyloides stercoralis in faecal samples using real-time PCR. Trans R Soc Trop Med Hyg 103: 342-346.
33. Zaha O, Hirata T, Kinjo F, Saito A, Fukuhara H, (2002) Efficacy of ivermectin for chronic strongyloidiasis: two single doses given 2 weeks apart. J Infect Chemother 8: 94-98.